FULCRUM THERAPEUTICS INC
FULC · NASDAQ
Updated at 2026-10-14 09:03:13
- Today's High
- $3.75
- Today’s Low
- $3.67
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.77
- Previous Close
- $3.75
- Volume
- 1.61M
- Market Cap
- $286.11M
- P/E Ratio
- --
- EPS
- $-0.89
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, UNITED STATES, 02139
- Country
- US
- Listing Date
- 2019-07-18
- Fiscal Year End
- December
- Shares Outstanding
- 66.63M
- CIK
- 0001680581
- Website
- www.fulcrumtx.com
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$19.69M
2026-03-31
$21.84M
2025-12-31
$22.99M
2025-09-30
$7.56M
Net Income
2026-06-30
-$26.17M
2026-03-31
-$18.89M
2025-12-31
-$20.33M
2025-09-30
-$19.59M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.28
2026-03-31
$-0.25
2025-12-31
$-0.31
2025-09-30
$-0.31
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$19.69M
2026-03-31
-$18.55M
2025-12-31
-$19.98M
2025-09-30
-$19.24M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $19.69M | $21.84M | $22.99M | $7.56M |
| Net Income | -$26.17M | -$18.89M | -$20.33M | -$19.59M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.28 | $-0.25 | $-0.31 | $-0.31 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$19.69M | -$18.55M | -$19.98M | -$19.24M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.